HER2 Support Group Forums - View Single Post - Trial information on herception prior to surgery

Jean · 02-12-2010, 10:37 AM

without chemo at MD Anderson.
Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast

The goal of this clinical research study is to find out if a single dose of the
drug Herceptin (trastuzumab) given before surgery can kill cancer cells or slow
the growth of cancer cells in women who have DCIS.
http://utm-ext01a.mdacc.tmc.edu/dept...ndex/2004-0701

jean

.
.

02-12-2010, 10:37 AM	#1
Jean Senior Member Join Date: Oct 2005 Location: New Jersey Posts: 3,154	Trial information on herception prior to surgery without chemo at MD Anderson. Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast The goal of this clinical research study is to find out if a single dose of the drug Herceptin (trastuzumab) given before surgery can kill cancer cells or slow the growth of cancer cells in women who have DCIS. http://utm-ext01a.mdacc.tmc.edu/dept...ndex/2004-0701 jean . . __________________ Stage 1, Grade 1, 3/30/05 Lumpectomy 4/15/05 - 6MM IDC Node Neg. (Sentinel node) ER+ 90% / PR-, Her2+++ by FISH Ki-67 40% Arimidex 5/05 Radiation 32 trt, 5/30/05 Oncotype DX test 4/17/06, 31% high risk TOPO 11 neg. 4/06 Stopped Arimidex 5/06 TCH 5/06, 6 treatments Herceptin 5/06 - for 1 yr. 9/06 Completed chemo Started Femara Sept. 2006